We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid, Cost Effective Method for Identifying UTI-Causing Bacteria

By LabMedica International staff writers
Posted on 01 Feb 2012
A new method for identifying bacteria that cause urinary tract infections (UTIs) will lead to faster, more effective treatment as well as a reduction in costs.

Scientists in Germany tested urine samples from hospitalized patients and were able to effectively separate and accurately identify bacteria using Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry.

The MALDI-TOF technique identifies bacteria by analyzing their proteins directly from the urine sample. More...
MALDI-TOF mass spectrometry works by firing pulses of UV light at biological samples. All the particles become charged and are then forced down a tunnel by an electrical force.

The speed of the particles depends on their mass; thus, biomolecules such as proteins or DNA can be identified. As bacteria do not need to be cultured on agar, the MALDI-TOF method reduces the time to identify UTI-causing bacteria to less than 30 minutes. In addition, MALDI-TOF can detect and identify bacteria at much lower levels than are needed for current standard diagnostic techniques.

The study was performed by scientists at the University Hospital Essen in Germany. Dr. Frank Mosel, who led the study, believes the MALDI-TOF method will have huge benefits for patients who suffer from UTIs. Dr. Mosel said, "Identifying bacteria quickly and accurately using MALDI-TOF means treatment for UTIs can be started at an early stage and with an antibiotic targeted at the correct bacterial culprit."

The MALDI-TOF technique is unaffected by any antibiotics the patient may have taken and the bacteria sample does not need to be cultured before testing. The sensitivity of the test is nearly 100 times higher than the minimum clinical threshold for UTI diagnosis.

Dr. Mosel believes that the use of MALDI-TOF mass spectrometry could be extended more widely as a medical analysis tool. "This method could quite feasibly be extended to blood, cerebrospinal fluid, and other bodily fluids to detect bacteria or even fungi," he said.

However, there are certain limitations to the MALDI-TOF methods for identifying bacteria. For example, bacteria in urine samples from patients who had undergone surgery for lower urinary tract (e.g., bladder) cancers could not be detected because human proteins produced interfered with the urine analysis.

Related Links:

University Hospital Essen



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.